Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Globus Medical, Inc. Class A Common Stock
(NY:
GMED
)
78.04
-4.87 (-5.87%)
Delayed Quote
Updated: 3:06 PM EDT, Oct 30, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Globus Medical, Inc. Class A Common Stock
< Previous
1
2
...
9
10
11
12
13
14
15
16
Next >
Globus Medical promotes Keith Pfeil to Chief Operating Officer and Chief Financial Officer
February 05, 2024
Pfeil takes on expanded responsibilities while Globus fuels its next phase of growth
From
Globus Medical
Via
GlobeNewswire
Why NYSE:GMED Is a Standout High-Growth Stock in a Consolidation Phase.
↗
January 30, 2024
GLOBUS MEDICAL INC - A (NYSE:GMED)—A High-Growth Stock Gearing Up for Its Next Upward Move.
Via
Chartmill
Do Investors Have Too Much Money Out of the Market?
↗
January 28, 2024
We've also got a look at two stocks worth watching: Globus Medical and RPM International.
Via
The Motley Fool
NYSE:GMED stands out as a growth opportunity that won't break the bank.
↗
January 17, 2024
Despite its growth, GLOBUS MEDICAL INC - A (NYSE:GMED) remains within the realm of affordability.
Via
Chartmill
7 Healthcare Stocks Taking Medicine to the Next Level
↗
January 14, 2024
With advances in technology potentially able to improve the human condition, these are the compelling healthcare stocks to consider.
Via
InvestorPlace
The Analyst Verdict: Globus Medical In The Eyes Of 6 Experts
↗
January 11, 2024
Via
Benzinga
NYSE:GMED qualifies as a high growth stock and is consolidating.
↗
January 09, 2024
GLOBUS MEDICAL INC - A (NYSE:GMED)—A High-Growth Stock Gearing Up for Its Next Upward Move.
Via
Chartmill
Investors seeking growth at a reasonable cost should explore NYSE:GMED.
↗
December 25, 2023
In the world of growth stocks, NYSE:GMED shines as a value proposition.
Via
Chartmill
Globus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales Results
January 10, 2024
From
Globus Medical
Via
GlobeNewswire
Assessing Globus Medical: Insights From 5 Financial Analysts
↗
December 20, 2023
Via
Benzinga
3 Stocks at the Forefront of Medical Robotics
↗
December 10, 2023
Although the concept of medical robotics stocks is incredibly risky, the sector also offers tremendous upside for the intrepid.
Via
InvestorPlace
For those who appreciate growth without the sticker shock, NYSE:GMED is worth considering.
↗
December 04, 2023
GLOBUS MEDICAL INC - A (NYSE:GMED) is not too expensive for the growth it is showing.
Via
Chartmill
NYSE:GMED: a strong growth stock preparing for the next leg up?.
↗
November 17, 2023
GLOBUS MEDICAL INC - A (NYSE:GMED) qualifies as a high growth stock and is consolidating.
Via
Chartmill
Expert Ratings for Globus Medical
↗
November 08, 2023
Via
Benzinga
Globus Medical: Q3 Earnings Insights
↗
November 07, 2023
Via
Benzinga
NYSE:GMED is showing good growth, while it is not too expensive.
↗
October 23, 2023
NYSE:GMED, a growth stock which is not overvalued.
Via
Chartmill
What 8 Analyst Ratings Have To Say About Globus Medical
↗
October 20, 2023
Via
Benzinga
Investors should take note of NYSE:GMED, a growth stock that remains attractively priced.
↗
November 13, 2023
Despite its growth, NYSE:GMED remains within the realm of affordability.
Via
Chartmill
Globus Medical (GMED) Q3 2023 Earnings Call Transcript
↗
November 07, 2023
GMED earnings call for the period ending September 30, 2023.
Via
The Motley Fool
Topics
Earnings
Globus Medical Reports Third Quarter 2023 Results
November 07, 2023
From
Globus Medical
Via
GlobeNewswire
Globus Medical Schedules Third Quarter Earnings Release and Conference Call
October 24, 2023
From
Globus Medical
Via
GlobeNewswire
The Latest Analyst Ratings for Globus Medical
↗
September 05, 2023
Via
Benzinga
Five-Year Study Outcomes of the NuVasive Simplify Cervical Disc were Presented at the North American Spine Society 38th Annual Meeting
October 24, 2023
From
Globus Medical
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For October 20, 2023
↗
October 20, 2023
Via
Benzinga
Twenty Years of the NuVasive XLIF Procedure Celebrated at the Society for Minimally Invasive Spine Surgery 2023 Annual Forum
October 10, 2023
From
Globus Medical
Via
GlobeNewswire
Globus Medical and NuVasive to Sponsor and Participate at EUROSPINE 2023
September 27, 2023
From
Globus Medical
Via
GlobeNewswire
Globus Medical's Untapped Potential Beyond The NUVA Transaction; Analyst Turns Bullish
↗
September 19, 2023
Stifel analyst Mathew Blackman upgraded Globus Medical, Inc. (NYSE: GMED) to Buy from Hold,
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 19, 2023
↗
September 19, 2023
Via
Benzinga
NuVasive Specialized Orthopedics Launches Precice Bone Transport in International Markets
September 07, 2023
From
Globus Medical
Via
GlobeNewswire
Globus Medical Completes Merger with NuVasive
September 01, 2023
From
Globus Medical
Via
GlobeNewswire
< Previous
1
2
...
9
10
11
12
13
14
15
16
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
